Drug intelligence / Profile preview

thiamine + pyridoxine + cyanocobalamin (P&B Pharmaceuticals)

Development stage
Unknown
Lead developer
P.B. Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Aneudox is a neurotropic vitamin B-complex supplement developed and manufactured by P&B Pharmaceuticals. It typically consists of a combination of thiamine (vitamin B1), pyridoxine (vitamin B6), and cyanocobalamin (vitamin B12), which are essential cofactors for metabolic processes in the central and peripheral nervous systems. Thiamine is critical for carbohydrate metabolism and energy production in nerve cells; pyridoxine is involved in the biosynthesis of neurotransmitters such as serotonin and GABA; and cyanocobalamin is vital for DNA synthesis and the maintenance of the myelin sheath. Aneudox is primarily indicated for the treatment and prevention of vitamin B deficiencies and peripheral neuropathies, including those associated with diabetes, alcoholism, or drug-induced nerve damage. A variant, Aneudox Plus, includes additional neuroprotective ingredients such as alpha-lipoic acid and folic acid to enhance its therapeutic effect in nerve health.

Brand names
AneudoxAneudox Plus
Other names
Vitamin B-complexNeurotropic B-vitamins

Beyond the preview

Go deeper on thiamine + pyridoxine + cyanocobalamin (P&B Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiamine + pyridoxine + cyanocobalamin (P&B Pharmaceuticals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call